Stay updated on FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Sign up to get notified when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.

Latest updates to the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a platform version update behind the page. This change represents a backend software bump and does not alter study content or visible information.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision label was updated from v3.6.1 to v3.6.3, indicating a newer version of the study details page.SummaryDifference0.0%

- Check32 days agoChange DetectedA new revision tag appears: v3.6.1 replaces the previous v3.6.0 on the page. This signals a small update to the page's underlying build rather than any changes to study information.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now displays a recruitment status update indicating enrollment has ended. It also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and adjusts/removes some header labels and revision identifiers (Intervention/Treatment and Revision: v3.5.5).SummaryDifference0.3%

- Check48 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, signaling a new version of the page. This appears to be a minor behind-the-scenes update and does not change the study details or visible content.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4. This reflects a newer build or release of the documentation on the page.SummaryDifference0.0%

Stay in the know with updates to FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.